Our system is currently under heavy load due to increased usage. We're actively working on upgrades to improve performance. Thank you for your patience.
2006
DOI: 10.1292/jvms.68.859
|View full text |Cite
|
Sign up to set email alerts
|

Study on the Porcinophilic Foot-and-Mouth Disease Virus I. Production and Characterization of Monoclonal Antibodies against VP1

Abstract: ABSTRACT. Monoclonal antibodies (MAbs) reported here were produced against the porcinophilic foot-and-mouth disease virus (FMDV) that caused the devastating swine disease on 1997 in Taiwan. A panel (25) of MAbs were found to react with VP1 of O/Taiwan/97 (O/ 97) by ELISA with various potencies. The biological identities of these VP1 reacting MAbs, such as neutralization activity, isotype and capability to distinguish between two serotype O FMDVs, O/97 and O/Taiwan/KM1/99 (O/99), were further analyzed. Eleven o… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
3
0

Year Published

2009
2009
2022
2022

Publication Types

Select...
4

Relationship

1
3

Authors

Journals

citations
Cited by 4 publications
(3 citation statements)
references
References 25 publications
0
3
0
Order By: Relevance
“…It is the most prevalent serotype worldwide, although there is no precise genetically explanation for this higher prevalence (Mason et al, 2003). Some lineages of the type O are restricted in their host range to suidea (Cheng et al, 2006), whereas others, like the Panasia strain, are not restricted to a specific host .…”
Section: Serotype Omentioning
confidence: 99%
“…It is the most prevalent serotype worldwide, although there is no precise genetically explanation for this higher prevalence (Mason et al, 2003). Some lineages of the type O are restricted in their host range to suidea (Cheng et al, 2006), whereas others, like the Panasia strain, are not restricted to a specific host .…”
Section: Serotype Omentioning
confidence: 99%
“…Previously, we determined that the Q10E MAb recognized site 1 based on a synthetic GH peptide on VP1 [ 22 ] and successfully proved the P11A MAb as the site 2 antibody using mutated VLP/VP2-S72N [ 15 ]. Meanwhile, the S11B MAb, a neutralizing antibody, was found not to recognize the unprocessed protomer P1.…”
Section: Resultsmentioning
confidence: 99%
“…The first and second immunizations were intraperitoneal injections. The third immunization and last injections three days before fusion were given to the anesthetic mice via intrasplenic route (1,5). Animals were bled and sera neutralization titers were examined to monitor the individual immune response.…”
Section: Mice Immunizationmentioning
confidence: 99%